Further evidence that MRI based measurement of midbrain neuromelanin may serve as a proxy measure of brain dopamine activity in psychiatric disorders

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
JournalNeuropsychopharmacology
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this